• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD28共刺激受体功能受到N-连接碳水化合物的负调控。

CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates.

作者信息

Ma Bruce Y, Mikolajczak Sebastian A, Yoshida Tetsuya, Yoshida Ryoko, Kelvin David J, Ochi Atsuo

机构信息

Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.

出版信息

Biochem Biophys Res Commun. 2004 Apr 23;317(1):60-7. doi: 10.1016/j.bbrc.2004.03.012.

DOI:10.1016/j.bbrc.2004.03.012
PMID:15047148
Abstract

CD28 is a cell surface glycoprotein expressed on T cells that modulates immune responses through its ability to transduce costimulatory signals. Even though nearly 50% of the molecular mass of CD28 is N-glycan, the physiological significance of CD28 glycosylation is at present unknown. In this report, we have investigated the function of hypoglycosylated wildtype CD28 and its splice variant, CD28i. When N-glycosylation was prevented through point mutations in N-glycosylation sites in CD28, or reduced by glycosidase inhibitors, the binding of CD28 to CD80 significantly increased. Stimulation of hypoglycosylated CD28 induced IL-2 promoter activity greater than that induced through the stimulation of wildtype CD28. Unlike hypoglycosylated wildtype CD28, hypoglycosylation of CD28i did not alter CD28i functions. Our data indicate that N-glycans of CD28 negatively regulate CD28/CD80 interactions, resulting in diminished CD28 signaling. It is also suggested that N-glycans regulate the density of CD28 clustering upon ligation with CD80/CD86. The results support the hypothesis that the N-glycosylation negatively regulates CD28-mediated T cell adhesion and costimulation.

摘要

CD28是一种表达于T细胞表面的糖蛋白,它通过转导共刺激信号来调节免疫反应。尽管CD28近50%的分子质量是N-聚糖,但目前CD28糖基化的生理意义尚不清楚。在本报告中,我们研究了低糖基化野生型CD28及其剪接变体CD28i的功能。当通过CD28中N-糖基化位点的点突变阻止N-糖基化,或用糖苷酶抑制剂降低N-糖基化时,CD28与CD80的结合显著增加。低糖基化CD28的刺激诱导的IL-2启动子活性大于野生型CD28刺激诱导的活性。与低糖基化野生型CD28不同,CD28i的低糖基化并未改变CD28i的功能。我们的数据表明,CD28的N-聚糖负向调节CD28/CD80相互作用,导致CD28信号减弱。还表明,N-聚糖在与CD80/CD86连接时调节CD28聚集的密度。这些结果支持了N-糖基化负向调节CD28介导的T细胞黏附和共刺激的假说。

相似文献

1
CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates.CD28共刺激受体功能受到N-连接碳水化合物的负调控。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):60-7. doi: 10.1016/j.bbrc.2004.03.012.
2
Two regions in the CD80 cytoplasmic tail regulate CD80 redistribution and T cell costimulation.CD80细胞质尾部的两个区域调节CD80的重新分布和T细胞共刺激。
J Immunol. 1998 Sep 15;161(6):2700-7.
3
Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation.CD80受体的亚细胞定位依赖于完整的细胞质尾巴,并且是CD28依赖的T细胞共刺激所必需的。
J Immunol. 1996 Oct 15;157(8):3270-9.
4
The immunological synapse and CD28-CD80 interactions.免疫突触与CD28-CD80相互作用。
Nat Immunol. 2001 Dec;2(12):1159-66. doi: 10.1038/ni737.
5
A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.一种新型双特异性四价抗体融合蛋白,用于靶向共刺激活性,以激活针对过表达ErbB2/HER2的肿瘤细胞的T细胞。
J Mol Biol. 2005 Mar 11;346(5):1299-311. doi: 10.1016/j.jmb.2004.12.052. Epub 2005 Jan 22.
6
Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway.
J Immunol. 1994 Sep 15;153(6):2515-23.
7
CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.CD28刺激通过CARMA1-PKCθ-Grb2/Gads轴触发核因子κB激活。
Int Immunol. 2008 Dec;20(12):1507-15. doi: 10.1093/intimm/dxn108. Epub 2008 Oct 1.
8
Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.通过B-7/CD28途径的T细胞共刺激参与载脂蛋白E基因敲除小鼠动脉粥样硬化斑块形成的证据。
Exp Mol Pathol. 2004 Jun;76(3):219-23. doi: 10.1016/j.yexmp.2003.12.001.
9
4-1BBL costimulation retrieves CD28 expression in activated T cells.4-1BBL共刺激可恢复活化T细胞中CD28的表达。
Cell Immunol. 2009;256(1-2):39-46. doi: 10.1016/j.cellimm.2009.01.003. Epub 2009 Feb 12.
10
CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.原代小鼠CD4 + T细胞上的CTLA4与CD80/CD86相互作用整合信号强度信息,以调节伴刀豆球蛋白A介导的激活。
J Leukoc Biol. 2005 Jul;78(1):144-57. doi: 10.1189/jlb.1104644. Epub 2005 Mar 23.

引用本文的文献

1
Unraveling the glyco-immunity nexus in pancreatic cancer.解析胰腺癌中的糖免疫关系
Mol Cancer. 2025 Aug 4;24(1):211. doi: 10.1186/s12943-025-02417-4.
2
Glycosylation as an intricate post-translational modification process takes part in glycoproteins related immunity.糖基化作为一个复杂的翻译后修饰过程,参与了与糖蛋白相关的免疫反应。
Cell Commun Signal. 2025 May 5;23(1):214. doi: 10.1186/s12964-025-02216-w.
3
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.肝细胞癌中的翻译后修饰:开启免疫治疗的新前沿
Front Immunol. 2025 Feb 18;16:1554372. doi: 10.3389/fimmu.2025.1554372. eCollection 2025.
4
Temporal resolved multi-proteomic analysis enabled the systematic characterization of N-glycosylation pattern changes during Jurkat T cell activation.时间分辨多蛋白质组分析能够系统地表征Jurkat T细胞活化过程中N-糖基化模式的变化。
Anal Bioanal Chem. 2025 Apr;417(10):2169-2183. doi: 10.1007/s00216-025-05805-3. Epub 2025 Feb 25.
5
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect.磷酸葡萄糖变位酶3缺乏症:一种导致显著T细胞缺陷的糖基化障碍疾病。
Front Immunol. 2024 Dec 24;15:1500381. doi: 10.3389/fimmu.2024.1500381. eCollection 2024.
6
Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function.肿瘤葡萄糖代谢与 T 细胞糖萼:对 T 细胞功能的影响。
Front Immunol. 2024 May 31;15:1409238. doi: 10.3389/fimmu.2024.1409238. eCollection 2024.
7
Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer.血浆蛋白质组学和代谢组学分析可预测老年晚期非小细胞肺癌患者的免疫相关不良事件。
iScience. 2024 May 8;27(6):109946. doi: 10.1016/j.isci.2024.109946. eCollection 2024 Jun 21.
8
Sweet regulation - The emerging immunoregulatory roles of hexoses.糖类调节——己糖新出现的免疫调节作用
J Adv Res. 2025 Mar;69:361-379. doi: 10.1016/j.jare.2024.04.014. Epub 2024 Apr 15.
9
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.糖基化影响多种蛋白、基因和细胞治疗的疗效和安全性。
Biotechnol Adv. 2023 Oct;67:108206. doi: 10.1016/j.biotechadv.2023.108206. Epub 2023 Jun 22.
10
The Glycosylation of Immune Checkpoints and Their Applications in Oncology.免疫检查点的糖基化及其在肿瘤学中的应用。
Pharmaceuticals (Basel). 2022 Nov 23;15(12):1451. doi: 10.3390/ph15121451.